<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>The Roslin Institute</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A990CA07-84D1-46D1-B0FC-05175C547912"><gtr:id>A990CA07-84D1-46D1-B0FC-05175C547912</gtr:id><gtr:name>National Academy of Medicine</gtr:name><gtr:address><gtr:line1>Department of Immunology</gtr:line1><gtr:line2>IIHEMA</gtr:line2><gtr:line3>Pacheco de Melo 3081</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A4ED6151-1937-4F9D-A0B2-D0F56EB882C8"><gtr:id>A4ED6151-1937-4F9D-A0B2-D0F56EB882C8</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Lawrence</gtr:otherNames><gtr:surname>Gally</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/02864FC6-23B6-43C9-AFC8-29854658787B"><gtr:id>02864FC6-23B6-43C9-AFC8-29854658787B</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Paul</gtr:otherNames><gtr:surname>Stevens</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AF340BB6-5251-4770-9CBF-0011591ED951"><gtr:id>AF340BB6-5251-4770-9CBF-0011591ED951</gtr:id><gtr:firstName>Andreas</gtr:firstName><gtr:surname>Lengeling</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FL026740%2F1"><gtr:id>6B818D81-017E-4015-98AD-5C0ACB690186</gtr:id><gtr:title>Tackling Enterohaemorrhagic E. coli infection across continents</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L026740/1</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2018-09-17</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-06-18</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>13163</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Argentina has some of the highest rates of kidney damage (HUS) due to E. coli O157 infection in the world. We have experise in the UK in understanding this organism and why certain strains are more likely to be associated with serious pathology. The partnership award had led to information exchange around this important issue and has allowed us to include Argentinian isolates in current seqeuncing projects for comparative studies. We have recently submitted a collaborative grant to BBSRC to investigate differences in strain pathogenesis.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>8F229C67-49BA-411C-B647-B2009960B20E</gtr:id><gtr:impactTypes/><gtr:outcomeId>5458e157951ba2.96353543</gtr:outcomeId></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>This is an international partnership award between The Roslin Instittue, Edinburgh and CONICET, Buenos Aires, Argentina focused on the issue of enterohaemorrhagic E.coli infections. There have been three funded research exchange trips to date and one joint publication. The award has enabled joint submission of a grant with two further research visits planned and one additional manuscript in preparation</gtr:description><gtr:exploitationPathways>full grant applications and international partnership to deal with a significant bacterial zoonosis</gtr:exploitationPathways><gtr:id>42A00B2B-3314-4CA4-B917-F2BFADEC8062</gtr:id><gtr:outcomeId>5458e11a2253a8.55926640</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Environment,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4859978B-A6BF-4C6E-A164-FF1967033EE1</gtr:id><gtr:title>Type III Secretion-Dependent Sensitivity of Escherichia coli O157 to Specific Ketolides.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8a445b3b267f3316dbe9e51e48e1e9b"><gtr:id>e8a445b3b267f3316dbe9e51e48e1e9b</gtr:id><gtr:otherNames>Fernandez-Brando RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>56d6d2b36e1dd4.16853098</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L026740/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>